27,99 €
inkl. MwSt.
Versandfertig in 6-10 Tagen
14 °P sammeln
Andere Kunden interessierten sich auch für
![Retinal Vein Occlusions]( "Retinal Vein Occlusions")
Retinal Vein Occlusions169,99 €![Retinal Vein Occlusions]( "Retinal Vein Occlusions")
Retinal Vein Occlusions154,99 €![Pathological Ocular Angiogenesis and Macular Edema in Diabetes]( "Pathological Ocular Angiogenesis and Macular Edema in Diabetes")
Pathological Ocular Angiogenesis and Macular Edema in Diabetes25,99 €![Edema macular relacionado con oclusiones venosas de la retina]( "Edema macular relacionado con oclusiones venosas de la retina")
Edema macular relacionado con oclusiones venosas de la retina28,99 €![Edema macular relacionado com oclusões de veias retinianas]( "Edema macular relacionado com oclusões de veias retinianas")
Edema macular relacionado com oclusões de veias retinianas28,99 €![Macular Edema]( "Macular Edema")
Macular Edema121,99 €![Macular Edema]( "Macular Edema")
Macular Edema116,99 €
Retinal vein occlusion is a common and potentially serious retinal pathology. Macular edema is the main cause of blindness in retinal vein occlusions. Its diagnosis and monitoring is based on optical coherence tomography, which is a non-invasive and rapid means of exploration that allows both quantitative and qualitative analysis. Its treatment is based on intravitreal injections of anti-VEGF (Vascular Endothelial Growth Factor) such as Bevacizumab, a widely used molecule.We propose to study the efficacy of intravitreal injections of Bevacizumab in the treatment of macular edema related to retinal vein occlusions based on tomographic data.